Swaraj Suiting Business Update

Swaraj Suiting Board Meeting Date

Swaraj Suiting will hold a board meeting on November 14, 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. The trading window is closed from October 1 to November 16, 2026.

Swaraj Suiting Preferential Issue

Swaraj Suiting allotted 4,65,000 equity shares to five investors under a preferential issue at Rs.236 each. The allotment raised about Rs.10.97 Crore.

Value

₹10.97 Cr

Swaraj Suiting Preferential Issue

Swaraj Suiting Limited allotted securities under a preferential issue, filed on BSE XBRL on 30 October 2026. The filing gives share counts but no explicit consideration for this allotment.

Swaraj Suiting Convertible Warrants

Swaraj Suiting allotted 4,65,000 shares on warrant conversion for Rs 8.23 Crore cash. Paid-up capital rises to Rs 26.88 Crore.

Value

₹8.23 Cr

Swaraj Suiting Preferential Issue

Swaraj Suiting held its EGM on 24 October 2026 to seek approval for a preferential issue of 35 lakh equity shares and 17 lakh convertible warrants at Rs.335 each. Voting results will be filed separately.

Value

₹174.2 Cr

Swaraj Suiting Preferential Issue

Swaraj Suiting issued a corrigendum amending the explanatory statement of its EGM notice regarding a Rs. 117.25 Crore preferential issue to investors.

Value

₹117.2 Cr

Italian Edibles Business Update

Italian Edibles revised its project timeline again, pushing commercial production from January 2027 to April 2027. Construction delays stem from steel prices, supply chain disruption, weather and labour shortages.

Execution

Commercial production revised to April 2027 from January 2027

Bajaj Finserv Business Update

Bajaj Finserv disclosed October 2026 monthly premium and new business data for its unlisted insurance subsidiaries. The figures are provisional.

Bajaj Finance Business Update

Bajaj Finance submitted its Half Yearly Report for FY2026-27 covering the six months to 30 September 2026. The report shows 28% consolidated PAT growth to ₹12,447 crore and a planned ₹17,500 crore capital raise.

Cohance Lifesciences Business Update

Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.

Religare Enterprises Business Update

Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.

Purple Wave Infocom Business Update

Purple Wave signed a 5-year data integration agreement with BPCL for its Hygiair devices. The Rs 10 crore figure is indicative, not firm order value.

Execution

5 years